CLINICAL_TRIALS
research
· 2018-06-12
Clinical Trial Update: Apremilast Treatment for Pruritus and Quality of Life in Scalp Psoriasis [Phase 4]
Summary
Phase 4 clinical trial update on apremilast for pruritus and quality of life in scalp psoriasis; current status is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Zurich | Conditions: Psoriasis of Scalp, Psoriasis Vulgaris | Phase 4 | Status: UNKNOWN